Menopause is a significant phase in a woman’s life that is often accompanied by various symptoms, including vasomotor symptoms (VMS) such as hot flushes and night sweats. A recent study led by Monash University sheds light on the prevalence of untreated VMS in perimenopausal women, highlighting the importance of timely recognition and management of these symptoms.
Published in The Lancet Diabetes & Endocrinology, the study is the first of its kind to delve into the differences between women in different stages of menopause. The research identified moderate to severe VMS and vaginal dryness as the most defining symptoms of perimenopause, showcasing a significant increase in prevalence compared to premenopause.
The study involved 5509 women aged 40-69 years, classified into premenopausal, early perimenopausal, late perimenopausal, and postmenopausal categories. Professor Susan Davis AO, the senior author of the study, emphasized the specificity of new-onset VMS in perimenopause, indicating a five-fold increase compared to premenopause.
Dr. Rakib Islam, the first author of the study, highlighted the methodological depth and national reach of the research, which linked menopausal stages with validated symptom profiles in over 5,500 women. This detailed approach is crucial for improving the identification and management of the menopause transition.
The findings suggest a more symptom-based approach to classifying women by menopause stage, enabling earlier recognition of perimenopause and more timely care. This shift in perspective could benefit women with regular cycles and those who no longer menstruate, ensuring they receive appropriate support and treatment.
Professor The Hon Jill Hennessy, Chair of Monash Women’s Health Alliance, emphasized the transformative impact of this research on women’s health treatment. By defining the symptoms that mark the menopause transition, the study empowers women and clinicians with better knowledge and tools to enhance women’s health and well-being.
Ultimately, this landmark study underscores the importance of listening to women, taking their symptoms seriously, and providing evidence-based care during perimenopause. By addressing the specific needs and challenges faced by women during menopause, healthcare providers can ensure that women receive the support and treatment they deserve.
For more information, the study titled “Prevalence and severity of symptoms across the menopause transition: cross-sectional findings from the Australian Women’s Midlife Years (AMY) Study” can be accessed in The Lancet Diabetes & Endocrinology. The DOI for the study is 10.1016/S2213-8587(25)00138-X.
This research was conducted by Monash University and represents a significant contribution to advancing women’s health and well-being. It is essential to acknowledge and address the unique experiences and symptoms that women may encounter during menopause, ensuring they receive the care and support necessary for a healthy transition.
